New study identifies potential drug targets for heart failure

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified into two major clinical subtypes- heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF).

Immigrant healthcare professionals: essential pillars of the U.S. health system

A study by The Baker Institute for Public Policy highlights the critical role of immigrant healthcare professionals in the U.S. health system, examining their increasing

January 8, 2024

MediciNova Inc Files Patent for Injectable Pharmaceutical Composition with SBE-ß-CD and Ibudilast

Share this article According to GlobalData’s company profile on MediciNova, Peptide pharmacophores was a key innovation area identified from patents. MediciNova‘s grant share as of

March 6, 2024

San Diego biotech secures $75M to advance lead candidate

Arthrosi Therapeutics, a biotech company developing a gout treatment, raised a fresh $75 million through a Series D round. According to a press release on

July 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.